Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controlling gene expression by zinc(II)-macrocyclic tetraamine complexes.

E Kikuta1, T Koike, E Kimura

  • 1Department of Medicinal Chemistry, Faculty of Medicine, Hiroshima University, Japan.

Journal of Inorganic Biochemistry
|June 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?

European journal of clinical pharmacology·2019
Same author

Glutamate Overproduction in Corynebacterium glutamicum Triggered by a Decrease in the Level of a Complex Comprising DtsR and a Biotin-containing Subunit.

Bioscience, biotechnology, and biochemistry·2016
Same author

Clinicians' prescribing practices for bariatric surgery patients: is there an issue?

Journal of clinical pharmacy and therapeutics·2014
Same author

Intestinal mast cells and eosinophils in relation to Strongyloides ratti adult expulsion from the small and large intestines of rats.

Parasitology·2013
Same author

Optineurin is potentially associated with TDP-43 and involved in the pathogenesis of inclusion body myositis.

Neuropathology and applied neurobiology·2012
Same author

Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease.

Alimentary pharmacology & therapeutics·2011

New zinc(II)-cyclen complexes selectively bind to thymines in DNA, inhibiting gene transcription and acting as antimicrobial agents. These compounds represent novel small molecules for genetic regulation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • The TATA box is a crucial DNA sequence in eukaryotic promoter regions, essential for transcription initiation.
  • TATA-binding protein (TBP) recognizes and binds to the TATA box, a critical step in gene regulation.
  • DNA topoisomerases are vital enzymes involved in managing DNA topology during replication and transcription.

Purpose of the Study:

  • To synthesize and characterize novel zinc(II) complexes with aryl-methyl appended macrocyclic tetraamines (cyclen).
  • To investigate the DNA-binding properties of these complexes, specifically their interaction with thymines in the SV40 early promoter TATA box.
  • To evaluate their potential as inhibitors of TBP, DNA topoisomerases, and their antimicrobial activities.

Main Methods:

Related Experiment Videos

  • Synthesis of zinc(II) complexes with 12-membered macrocyclic tetraamines (cyclen) functionalized with quinolyl-methyl, naphthyl-methyl, and acridinyl-methyl groups.
  • DNA-binding assays to assess selective binding to thymines within the SV40 early promoter TATA box.
  • Enzyme inhibition assays for type I and type II topoisomerases.
  • Antimicrobial activity testing against gram-positive bacterial strains.
  • Comparative analysis with established drugs like distamycin A and DAPI.

Main Results:

  • The synthesized Zn2+-cyclen derivatives selectively bind to thymines in the TATA box region of the SV40 early promoter.
  • These complexes effectively inhibit the binding of the TATA-binding protein (TBP).
  • The Zn2+-cyclen derivatives demonstrate inhibitory activity against both type I and type II topoisomerases.
  • Significant antimicrobial activity was observed against gram-positive bacteria.
  • The efficacy was comparable to established AT-recognizing drugs.

Conclusions:

  • Zn2+-cyclen complexes represent a new class of small molecular compounds with potential as genetic transcriptional regulation factors.
  • These compounds exhibit dual functionality as inhibitors of transcription factors and DNA-modifying enzymes.
  • Their potent antimicrobial properties suggest therapeutic applications.